Effects of dimethyl sulfoxide and thiourea upon intercalator-induced DNA single-strand breaks in mouse leukemia (L 1210) cells = Effets du diméthyl sulfoxyde et de la thiourée sur les cassures monocaténaires du DNA induites par agent intercalant dans les cellules de leucémie L1210 de sourisPOMMIER, Y; ZWELLING, L. A; MATTERN, M. R et al.Cancer research (Baltimore). 1983, Vol 43, Num 12, pp 5718-5724, issn 0008-5472Article

Cytotoxic effects of dexamethasone restricted to noncycling, early Gl-phase cells of L1210 leukemiaSMETS, L. A; BOUT, B; BROUWER, M et al.Journal of cellular physiology. 1983, Vol 116, Num 3, pp 397-403, issn 0021-9541Article

Ricin A-chain conjugated with monoclonal anti-L1210 antibody. In vitro and in vitro antitumor activityKISHIDA, K; MASUHO, Y; SAITO, M et al.Cancer immunology and immunotherapy. 1983, Vol 16, Num 2, pp 93-97, issn 0340-7004Article

Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias = Influence de la proportion molaire sur l'effet de l'association 5-fluoro-uracile, guanosine 5' monophosphate sur les leucémies P388 et L1210IIGO, M; HOSHI, A.European journal of cancer & clinical oncology. 1984, Vol 20, Num 3, pp 411-415, issn 0277-5379Article

Synergistic interaction between acivicin (AT-125) and 6-thioguanine in the murine leukemia L1210: biochemical and cytokinetic considerationsKAPIL BHALLA; RABINANDRETH NAYAK; DEITCH, A et al.Biochemical pharmacology. 1984, Vol 33, Num 2, pp 247-254, issn 0006-2952Article

Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells = Modulation sensible de la synergie entre la méthotrexate et le 5-fluorouracile en séquence dans les cellules murines L1210 par le thymidine et l'hypoxanthinePIPER, A. A; NOTT, S. E; MACKINNON, W. B et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5101-5105, issn 0008-5472Article

Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light = Modification des effets chimiothérapeutiques sur les cellules L1210 à l'aide d'hématoporphyrine et de la lumièreCREEKMORE, S. P; ZAHARKO, D. S.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5252-5257, issn 0008-5472Article

LINFOCITI IMMUNI CITOTOSSICI PER CELLULE LEUCEMICHE MODIFICATE NEL LORO POTERE ANTIGENICO = LYMPHOCYTES IMMUNS CYTOTOXIQUES POUR LES CELLULES LEUCEMIQUES MODIFIEES DANS LEUR POUVOIR ANTIGENIQUEBINI A; FRANCO P; NICOLIN A et al.1972; ARCH. ITAL. PATOL. CLIN. TUMORI; ITAL.; DA. 1972; VOL. 15; NO 1-4; PP. 37-44; ABS. ANGL.; BIBL. 11REF.Serial Issue

INCREASED CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY IN LEUKAEMIC LYMPHOCYTES.HAIT WN; WEISS B.1976; NATURE; G.B.; DA. 1976; VOL. 259; NO 5541; PP. 321-323; BIBL. 30 REF.Article

INFLUENCE OF STRESS ON LESION GROWTH AND ON SURVIVAL OF ANIMALS BEARING PARENTERAL AND INTRACEREBRAL LEUKEMIA L1210 AND WALKER TUMORS = INFLUENCE DU STRESS SUR LA CROISSANCE DES LESIONS ET LA SURVIE D'ANIMAUX, AYANT DES LEUCEMIES L1210 PARENTERALES ET INTRACEREBRALES ET DES TUMEURS DE WALKERGERSHBEIN LL; BENUCK I; SHURRAGER PS et al.1975; ONCOLOGY; SWITZ.; DA. 1975; VOL. 30; NO 5; PP. 429-435; BIBL. 1P.Article

ENTKERNUNG VON EHRLICH-ASCITES-UND LEUKAEMIE-L 1210-TUMORZELLEN IN SUSPENSION = LA DENUCLEATION DES CELLULES TUMORALES D'ASCITE D'EHRLICH ET DE LEUCEMIE L 1210 EN SUSPENSIONWACKER A; KAUL S.1975; NATURWISSENSCHAFTEN; DTSCH.; DA. 1975; VOL. 62; NO 10; PP. 494; BIBL. 2 REF.Article

IMMUNOGENICITY OF LEUKEMIA L1210 CELLS AFTER NEURAMINIDASE TREATMENT = IMMUNOGENICITE DES CELLULES DE LA LEUCEMIE L1210 APRES TRAITEMENT PAR LA NEURAMINIDASEBESEKI JG; ARNEAULT GS; WALTER L et al.1972; J. NATION. CANCER INST.; U.S.A.; DA. 1972; VOL. 49; NO 1; PP. 107-118; BIBL. 2P.Serial Issue

THE PHYSIOLOGICAL DISPOSITION OF 5-FLUOROURACIL IN MICE BEARING SOLID L1210 LYMPHOCYTIC LEUKEMIA = LE METABOLISME DU FLUORO-5 URACILE CHEZ LES SOURIS PORTEUSES D'UNE LEUCEMIE LYMPHOCYTAIRE L1210 SOLIDECHADWICK M; ROGERS WI.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 5; PP. 1045-1056; BIBL. 43REF.Serial Issue

X-RAY REPAIR REPLICATION IN L1210 LEUKEMIA CELLS = LA REPLICATION DE REPARATION DES RAYONS X DANS LES CELLULES DE LA LEUCEMIE L1210LEE YC; BYFIELD JE; BENNETT LR et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 10; PP. 2624-2633; BIBL. 31REF.Article

COMPLETE INHIBITION OF MOUSE LYMPHOID LEUKEMIA L-1210 BY CARBAZILQUINONE = INHIBITION COMPLETE DE LA LEUCEMIE LYMPHOIDE DE LA SOURIS L1210 PAR LA CARBAZILQUINONEARAKAWA M.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 14; PP. 487-489; BIBL. 3 REF.Serial Issue

INFLUENCE OF ROUTE OF ADMINISTRATION OF ANTILEUKEMIC ACTIVITY OF CYCLOCYTIDINE = INFLUENCE DE LA VOIE D'ADMINISTRATION SUR L'ACTION ANTILEUCEMIQUE DE LA CYCLOCYTIDINEHOSHI A; KANZAWA F; KURETANI K et al.1972; GANN; JAP.; DA. 1972; VOL. 63; NO 2; PP. 279-280; BIBL. 3 REF.Serial Issue

KINETICS OF THE REDUCTION IN VIABILITY OF CULTURED L1210 LEUKEMIA CELLS EXPOSED TO 5-AZACYTIDINE (NSC-102816)LLOYD HH; DULMADGE EA; WILLKOFF LJ et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 5; PP. 585-591; BIBL. 1P.1/2Serial Issue

INCREASED EFFICIENCY OF ANTILEUKEMIC CHEMOTHERAPY COMBINED WITH ALLOGENEIC SPLEEN CELLS DIFFERING FOR MINOR HISTOCOMPATIBILITY = EFFICACITE ACCRUE DE LA CHIMIOTHERAPIE ANTILEUCEMIQUE COMBINEE A DES CELLULES DE RATE ALLOGENIQUES AYANT UNE FAIBLE DIFFERENCE D'HISTOCOMPATIBILITEBONMASSAR E; BONMASSAR A; VADLAMUDI S et al.1971; ARCH. ITAL. PATOL. CLIN. TUMORI; ITAL.; DA. 1971; VOL. 14; NO 1-4; PP. 15-28; ABS. ITAL.; BIBL. 2P.Serial Issue

Increased cytotoxicity of N⁶-(Δ²-isopentenyl) adenosine in combination with pentostatin against L-1210 leukemia cells = Cytotoxicité accrue de la N6-(delta2-isopentényl) adénosine en association avec la pentostatine pour les cellules de leucémie L1210HACKER, B; YUNIK CHANG.Journal of pharmaceutical sciences. 1983, Vol 72, Num 10, pp 1225-1226, issn 0022-3549Article

INFLUENCE OF THE STAGE OF ADVANCEMENT OF LEUKEMIA L1210 IN MICE ON THE OPTIMAL SCHEDULE OF TREATMENT OF CYTOSINE ARABINOSIDE (NSC-63878) = INFLUENCE DU STADE DE L'EVOLUTION DE LA LEUCEMIE L1210 CHEZ LA SOURIS SUR LA POSOLOGIE MAXIMALE DANS LE TRAITEMENT PAR LE CYTOSINE ARABINOSIDE (NSC 63878)KLINE I; WOODMAN RJ; GANG M et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 3; PP. 327-334; BIBL. 31REF.Serial Issue

THE EFFECT OF CHEMOTHERAPY ON THE GROWTH OF LEUKEMIA L1210. II. PERSISTENCE OF A NITROSOUREA-INDUCED CHANGE IN THE GROWTH CHARACTERISTICS OF TRANSPLANT GENERATIONS = EFFET DE LA CHIMIOTHERAPIE SUR LA CROISSANCE DE LA LEUCEMIE L1210. II. PERSISTENCE D'UNE MODIFICATION INDUITE PAR LA NITROSOUREE DANS LES CARACTERISTIQUES DE CROISSANCE DES GENERATIONS DE TRANSPLANTSDEVITA VT; BRAY DA; BOSTICK F et al.1972; CELL TISSUE KINET.; G.B.; DA. 1972; VOL. 5; NO 6; PP. 459-566; BIBL. 9 REF.Serial Issue

Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia cells = Spécificité du système de transport des polyamines liée à la longueur de la chaîne aliphatique dans les cellules ascitiques L1210 leucémiquesPORTER, C. W; MILLER, J; BERGERON, R. J et al.Cancer research (Baltimore). 1984, Vol 44, Num 1, pp 126-128, issn 0008-5472Article

Cell kinetic studies of the cytostatic and cytocidal effects of 1-β-D-arabinofuranosylcytosine on the L1210 ascites tumor = Etudes par la cinétique cellulaire des effets cytostatiques et cytocide de la 1-bêta-D arabinofuranosylcytosine sur la tumeur ascitique L1210FIETKAU, R; FRIEDE, H; MAURER-SCHULTZE, B et al.Cancer research (Baltimore). 1984, Vol 44, Num 3, pp 1105-1113, issn 0008-5472Article

Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-β-D-arabinofuranosylcytosine of hydroxyurea in L1210 cellsMINFORD, J; KERRIGAN, D; NICHOLS, M et al.Cancer research (Baltimore). 1984, Vol 44, Num 12, pp 5583-5593, issn 0008-5472, 1Article

Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemiaHILTON, J.Cancer research (Baltimore). 1984, Vol 44, Num 11, pp 5156-5160, issn 0008-5472Article